307 related articles for article (PubMed ID: 31578597)
1. [Chronic kidney disease-a cardiovascular high-risk constellation].
Speer T; Schunk SJ; Fliser D
Internist (Berl); 2020 Apr; 61(4):340-348. PubMed ID: 31578597
[TBL] [Abstract][Full Text] [Related]
2. Heart and kidney disease: a cardiovascular high-risk constellation.
Schunk SJ; Speer T; Fliser D
Herz; 2021 Jun; 46(3):206-211. PubMed ID: 33377985
[TBL] [Abstract][Full Text] [Related]
3. Role of Uremic Toxins in Early Vascular Ageing and Calcification.
Kyriakidis NC; Cobo G; Dai L; Lindholm B; Stenvinkel P
Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33401534
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of cardiovascular comorbidities in uremic patients on chronic dialysis: metabolic derangements and cardiovascular risk].
Malberti F
G Ital Nefrol; 2012; 29 Suppl 58():S61-7. PubMed ID: 23229605
[TBL] [Abstract][Full Text] [Related]
5. Arterial stiffness and increased cardiovascular risk in chronic kidney disease.
Ma Y; Zhou L; Dong J; Zhang X; Yan S
Int Urol Nephrol; 2015 Jul; 47(7):1157-64. PubMed ID: 25991557
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease.
Moradi H; Sica DA; Kalantar-Zadeh K
Am J Nephrol; 2013; 38(2):136-48. PubMed ID: 23941724
[TBL] [Abstract][Full Text] [Related]
7. [Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD)].
Minami J; Ishimitsu T; Sudo Y; Matsuoka H
Nihon Rinsho; 2008 Sep; 66(9):1657-63. PubMed ID: 18788391
[TBL] [Abstract][Full Text] [Related]
8. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation.
Wojtaszek E; Oldakowska-Jedynak U; Kwiatkowska M; Glogowski T; Malyszko J
Oxid Med Cell Longev; 2021; 2021():6651367. PubMed ID: 33628373
[TBL] [Abstract][Full Text] [Related]
9. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
[TBL] [Abstract][Full Text] [Related]
10. Pediatric CKD and cardiovascular disease.
Safder O; Al sharif S; Kari JA
Cardiovasc Hematol Disord Drug Targets; 2014; 14(3):177-84. PubMed ID: 24720458
[TBL] [Abstract][Full Text] [Related]
11. Effects of Chronic Kidney Disease and Uremic Toxins on Extracellular Vesicle Biology.
Yaker L; Kamel S; Ausseil J; Boullier A
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33371311
[TBL] [Abstract][Full Text] [Related]
12. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.
Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S
Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232
[TBL] [Abstract][Full Text] [Related]
13. Uremic toxins: some thoughts on acrolein and spermine.
Sindhu KK
Ren Fail; 2016 Nov; 38(10):1755-1758. PubMed ID: 27758122
[TBL] [Abstract][Full Text] [Related]
14. Uremic Toxins Affecting Cardiovascular Calcification: A Systematic Review.
Holmar J; de la Puente-Secades S; Floege J; Noels H; Jankowski J; Orth-Alampour S
Cells; 2020 Nov; 9(11):. PubMed ID: 33172085
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease and its relationship with chronic kidney disease.
Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487
[TBL] [Abstract][Full Text] [Related]
16. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease.
Wu CL; Tarng DC
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312
[TBL] [Abstract][Full Text] [Related]
17. [Vascular dysfunction in Cardiorenal Syndrome type 4].
Sessa C; Granata A; Gaudio A; Xourafa A; Malatino L; Lentini P; Fatuzzo P; Rapisarda F; Castellino P; Zanoli L
G Ital Nefrol; 2020 Feb; 37(1):. PubMed ID: 32068357
[TBL] [Abstract][Full Text] [Related]
18. Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease.
Larivière R; Gauthier-Bastien A; Ung RV; St-Hilaire J; Mac-Way F; Richard DE; Agharazii M
J Hypertens; 2017 Feb; 35(2):376-384. PubMed ID: 28005706
[TBL] [Abstract][Full Text] [Related]
19. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
20. Uremic Toxins and Their Relation with Oxidative Stress Induced in Patients with CKD.
Pieniazek A; Bernasinska-Slomczewska J; Gwozdzinski L
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
